HRTX
Heron Therapeutics Inc

7,353
Mkt Cap
$231.04M
Volume
1.14M
52W High
$2.68
52W Low
$0.9999
PE Ratio
-15.57
HRTX Fundamentals
Price
$1.26
Prev Close
$1.21
Open
$1.22
50D MA
$1.33
Beta
1.40
Avg. Volume
1.63M
EPS (Annual)
-$0.0891
P/B
32.89
Rev/Employee
$1.18M
Loading...
Loading...
News
all
press releases
New York State Common Retirement Fund Buys 816,671 Shares of Heron Therapeutics, Inc. $HRTX
New York State Common Retirement Fund raised its stake in Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 46.4% in the 3rd quarter, according to the company in its most recent disclosure with...
MarketBeat·6h ago
News Placeholder
More News
News Placeholder
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Get Free Report) have earned an average recommendation of "Hold" from the five analysts that are presently covering the firm, MarketBeat reports. One...
MarketBeat·21d ago
News Placeholder
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Average Recommendation of "Hold" from Analysts
Heron Therapeutics, Inc. (NASDAQ:HRTX - Get Free Report) has been assigned a consensus rating of "Hold" from the five brokerages that are currently covering the company, MarketBeat Ratings reports...
MarketBeat·2mo ago
News Placeholder
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Consensus Recommendation of "Hold" by Analysts
Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Get Free Report) have earned a consensus recommendation of "Hold" from the five research firms that are presently covering the stock, Marketbeat...
MarketBeat·2mo ago
News Placeholder
Heron Therapeutics, Inc. $HRTX Shares Sold by Orchard Capital Management LLC
Orchard Capital Management LLC lowered its stake in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 53.9% in the second quarter, according to its most recent Form 13F filing with...
MarketBeat·2mo ago
News Placeholder
Jefferies Financial Group Inc. Acquires 344,200 Shares of Heron Therapeutics, Inc. $HRTX
Jefferies Financial Group Inc. boosted its stake in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 106.7% during the 2nd quarter, according to its most recent 13F filing with the...
MarketBeat·2mo ago
News Placeholder
What is Northland Capmk's Estimate for HRTX FY2026 Earnings?
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Equities research analysts at Northland Capmk issued their FY2026 earnings estimates for Heron Therapeutics in a research report issued to...
MarketBeat·3mo ago
News Placeholder
What is HC Wainwright's Forecast for HRTX FY2025 Earnings?
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Equities research analysts at HC Wainwright dropped their FY2025 earnings per share (EPS) estimates for Heron Therapeutics in a research note...
MarketBeat·3mo ago
News Placeholder
What is HC Wainwright's Forecast for HRTX FY2027 Earnings?
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Research analysts at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for Heron Therapeutics in a report released on Tuesday...
MarketBeat·3mo ago
News Placeholder
Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·3mo ago
<
1
2
...
>

Latest HRTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.